Nucleoside analogues are currently the main drug therapy against HBV infection. However, this type of therapy can cause gene mutations in HBV that result in drug resistance.
核苷类药物是目前抗乙型肝炎病毒(HBV)的主要药物，但它可引起HBV基因的变异，从而引起耐药。
Nucleoside analogues are currently the main drug therapy against HBV infection. However, this type of therapy can cause gene mutations in HBV that result in drug resistance.
核苷类药物是目前抗乙型肝炎病毒(HBV)的主要药物，但它可引起HBV基因的变异，从而引起耐药。
应用推荐